These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 4624794)
1. A study in Hong Kong to evaluate the role of pretreatment susceptibility tests in the selection of regiments of chemotherapy for pulmonary tuberculosis. Hong Kong Tuberculosis Treatment Services-British Medical Research Council Investigation. Am Rev Respir Dis; 1972 Jul; 106(1):1-22. PubMed ID: 4624794 [No Abstract] [Full Text] [Related]
2. Implications of the Hong Kong Study of policies of sensitivity testing. Mitchison DA Bull Int Union Tuberc; 1972 Feb; 47():9-14. PubMed ID: 5077110 [No Abstract] [Full Text] [Related]
3. A study in Hong Kong to evaluate the role of pretreatment susceptibility tests in the selection of regimens of chemotherapy for pulmonary tuberculosis--second report. A Hong Kong Tuberculosis Treatment Services/British Medical Research Council Investigation. Tubercle; 1974 Sep; 55(3):169-92. PubMed ID: 4220080 [No Abstract] [Full Text] [Related]
4. The effect of acceptable and adequate outpatient treatment on the length of hospitalization and on readmission for relapse or reactivation of pulmonary tuberculosis. Curry FJ Chest; 1973 Apr; 63(4):536-46. PubMed ID: 4633013 [No Abstract] [Full Text] [Related]
5. Hong Kong Policy Study for sensitivity testing: the main results. Allan WG Bull Int Union Tuberc; 1972 Feb; 47():3-8. PubMed ID: 5077118 [No Abstract] [Full Text] [Related]
6. Co-operative controlled trial of a standard regimen of streptomycin, PAS and isoniazid and three alternative regimens of chemotherapy in Britain. A report from the British Medical Research Council. Tubercle; 1973 Jun; 54(2):99-129. PubMed ID: 4203162 [No Abstract] [Full Text] [Related]
7. [Proceedings: Results of a controlled trial of intermittent ambulatory therapy of infectious pulmonary tuberculosis with comparison of various maintenance regimens]. Ganguin HG; Cramer G; Götz J; Holzhauer H; Niegsch G; Sieler H; Velten G; Völker L Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):107-15. PubMed ID: 4203235 [No Abstract] [Full Text] [Related]
8. Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 months. Hong Kong Chest Service/British Medical Research Council. Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):700-6. PubMed ID: 1901199 [TBL] [Abstract][Full Text] [Related]
9. Comparison of two regimens of simplified two-stage chemotherapy in previously untreated pulmonary tuberculosis. Bethlem N; Gerhardt FO G; Magarăo S Tubercle; 1973 Sep; 54(3):180-4. PubMed ID: 4204111 [No Abstract] [Full Text] [Related]
10. A controlled study of rifabutin and an uncontrolled study of ofloxacin in the retreatment of patients with pulmonary tuberculosis resistant to isoniazid, streptomycin and rifampicin. Hong Kong Chest Service/British Medical Research Council. Tuber Lung Dis; 1992 Feb; 73(1):59-67. PubMed ID: 1326349 [TBL] [Abstract][Full Text] [Related]
11. A controlled trial of 3-month, 4-month, and 6-month regimens of chemotherapy for sputum-smear-negative pulmonary tuberculosis. Results at 5 years. Hong Kong Chest Service/Tuberculosis Research Centre, Madras/British Medical Research Council. Am Rev Respir Dis; 1989 Apr; 139(4):871-6. PubMed ID: 2648911 [TBL] [Abstract][Full Text] [Related]
12. Primary isoniazid-resistant tuberculosis in children. Clinical features, strain resistance, treatment, and outcome in 26 children treated at Kings County Medical Center of Brooklyn between the years 1961 and 1972. Steiner P; Rao M; Victoria M; Steiner M Am Rev Respir Dis; 1974 Sep; 110(3):306-11. PubMed ID: 4213311 [No Abstract] [Full Text] [Related]
13. [Comparative results of treatment of pulmonary tuberculosis with the compounds of benzoyl-PAS-Ca-isoniazide and streptomycin-isoniazid]. Favez G; Gonin JD; Gubéran E; de Kalbermatten JP; Vulliémoz P; Willa C Schweiz Med Wochenschr; 1969 Feb; 99(5):150-6. PubMed ID: 4974643 [No Abstract] [Full Text] [Related]
14. Short-course chemotherapy for pulmonary tuberculosis. Fox W; Mitchison DA Am Rev Respir Dis; 1975 Mar; 111(3):325-53. PubMed ID: 47233 [No Abstract] [Full Text] [Related]
15. [Place of bacteriological examination in the treatment of tuberculosis]. Gyselen A Acta Tuberc Pneumol Belg; 1972; 63(4):405-8. PubMed ID: 4206438 [No Abstract] [Full Text] [Related]
16. The antituberculosis efficacy of rifampin in 136 patients. Davidson PT; Goble M; Lester W Chest; 1972 Jun; 61(6):574-8. PubMed ID: 4624279 [No Abstract] [Full Text] [Related]
17. Tuberculosis in Kenya: a follow-up of a national sampling survey of drug resistance and other factors. An East African and British Medical Research Council co-operative investigation. Tubercle; 1970 Mar; 51(1):1-23. PubMed ID: 4099825 [No Abstract] [Full Text] [Related]
18. [Use of 4 antibacterial preparations in the treatment of destructive tuberculosis of the lungs]. Volkon VM; Shrentsel' OA Probl Tuberk; 1973; 51(6):28-31. PubMed ID: 4202910 [No Abstract] [Full Text] [Related]